Home / Blog – MesotheliomaHelp.org / Partnership Turns Focus to Targeted Therapy for Mesothelioma Patients

Partnership Turns Focus to Targeted Therapy for Mesothelioma Patients

Immunotherapy is still a relatively new treatment for mesothelioma and other cancers, and researchers continue to work to increase its effectiveness. In the latest news involving the immunotherapy drug Keytruda, shown effective in some mesothelioma patients, the maker of the drug is joining efforts with a company that develops companion diagnostics for immuno-oncology drugs. The collaboration could bring personalized care one step closer to mesothelioma patients. Last month, Foundation Medicine announced that they signed a deal with Merck that will use the company’s FoundationOne CDx™ genomic profiling assay to create a pan-cancer companion diagnostic to measure microsatellite instability (MSI), tumor […]

The post Partnership Turns Focus to Targeted Therapy for Mesothelioma Patients appeared first on MesotheliomaHelp.org.



from Blog – MesotheliomaHelp.org https://ift.tt/2xELA2u
via IFTTT
Partnership Turns Focus to Targeted Therapy for Mesothelioma Patients Partnership Turns Focus to Targeted Therapy for Mesothelioma Patients Reviewed by Unknown on June 04, 2018 Rating: 5

No comments:

Subscribe to: Post Comments ( Atom )
Powered by Blogger.